DEPARTMENT OF PEDIATRIC ONCOLOGY
Welcome to the clinical study page for the Department of Pediatric Oncology at the Columbia University Medical Center.

View Studies By Physician
Larisa Broglie, MD, MS
Nobuko Hijiya, MD
Alice Lee, MD
Cindy Neunert, MD
Luca Szalontay, MD
Stergios Zacharoulis, MD
Investigator
investigator name
Phone
phone number
Email
email
bio
biography

View Studies By Condition:
Show All Studies
Pediatrics
Leukemia
Childhood Leukemia
Lymphoma
Cancer
Condition Study Title Investigator
Childhood Leukemia PEPN2113: Study of Uproleselan in Children with AML, MDS, or MPAL Luca Szalontay, MD
Cancer Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) Nobuko Hijiya, MD
Lymphoma Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) Nobuko Hijiya, MD
Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) Luca Szalontay, MD
Childhood Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) Luca Szalontay, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Luca Szalontay, MD
Pediatrics ICON3: A Phase 3 Study of Eltrombopag vs. Standard Therapy for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Cindy Neunert, MD
Childhood Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Luca Szalontay, MD